1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global HER2 Targeted Therapy Market Size 2016-2026 2.1.2 HER2 Targeted Therapy Market Size CAGR by Region 2020 VS 2021 VS 2026 2.2 HER2 Targeted Therapy Segment by Type 2.2.1 Monotherapy 2.2.2 Monotherapy 2.2.3 Others 2.3 HER2 Targeted Therapy Market Size by Type 2.3.1 Global HER2 Targeted Therapy Market Size CAGR by Type 2.3.2 Global HER2 Targeted Therapy Market Size Market Share by Type (2016-2021) 2.4 HER2 Targeted Therapy Segment by Application 2.4.1 Breast Cancer 2.4.2 Stomach Cancer 2.4.3 Head and Neck Cancer 2.4.4 Lung Cancer 2.4.5 Ovarian Cancer 2.4.6 Others 2.5 HER2 Targeted Therapy Market Size by Application 2.5.1 Global HER2 Targeted Therapy Market Size CAGR by Application 2.5.2 Global HER2 Targeted Therapy Market Size Market Share by Application (2016-2021) 3 HER2 Targeted Therapy Market Size by Players 3.1 HER2 Targeted Therapy Market Size Market Share by Players 3.1.1 Global HER2 Targeted Therapy Revenue by Players (2019-2021E) 3.1.2 Global HER2 Targeted Therapy Revenue Market Share by Players (2019-2021E) 3.2 Global HER2 Targeted Therapy Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 HER2 Targeted Therapy by Regions 4.1 HER2 Targeted Therapy Market Size by Regions (2016-2021) 4.2 Americas HER2 Targeted Therapy Market Size Growth (2016-2021) 4.3 APAC HER2 Targeted Therapy Market Size Growth (2016-2021) 4.4 Europe HER2 Targeted Therapy Market Size Growth (2016-2021) 4.5 Middle East & Africa HER2 Targeted Therapy Market Size Growth (2016-2021) 5 Americas 5.1 Americas HER2 Targeted Therapy Market Size by Country (2016-2021) 5.2 Americas HER2 Targeted Therapy Market Size by Type (2016-2021) 5.3 Americas HER2 Targeted Therapy Market Size by Application (2016-2021) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC HER2 Targeted Therapy Market Size by Region (2016-2021) 6.2 APAC HER2 Targeted Therapy Market Size by Type (2016-2021) 6.3 APAC HER2 Targeted Therapy Market Size by Application (2016-2021) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe HER2 Targeted Therapy by Country (2016-2021) 7.2 Europe HER2 Targeted Therapy Market Size by Type (2016-2021) 7.3 Europe HER2 Targeted Therapy Market Size by Application (2016-2021) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa HER2 Targeted Therapy by Region (2016-2021) 8.2 Middle East & Africa HER2 Targeted Therapy Market Size by Type (2016-2021) 8.3 Middle East & Africa HER2 Targeted Therapy Market Size by Application (2016-2021) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers and Impact 9.1.1 Growing Demand from Key Regions 9.1.2 Growing Demand from Key Applications and Potential Industries 9.2 Market Challenges and Impact 9.3 Market Trends 10 Global HER2 Targeted Therapy Market Forecast 10.1 Global HER2 Targeted Therapy Forecast by Regions (2021-2026) 10.1.1 Global HER2 Targeted Therapy Forecast by Regions (2021-2026) 10.1.2 Americas HER2 Targeted Therapy Forecast 10.1.3 APAC HER2 Targeted Therapy Forecast 10.1.4 Europe HER2 Targeted Therapy Forecast 10.1.5 Middle East & Africa HER2 Targeted Therapy Forecast 10.2 Americas HER2 Targeted Therapy Forecast by Countries (2021-2026) 10.2.1 United States HER2 Targeted Therapy Market Forecast 10.2.2 Canada HER2 Targeted Therapy Market Forecast 10.2.3 Mexico HER2 Targeted Therapy Market Forecast 10.2.4 Brazil HER2 Targeted Therapy Market Forecast 10.3 APAC HER2 Targeted Therapy Forecast by Region (2021-2026) 10.3.1 China HER2 Targeted Therapy Market Forecast 10.3.2 Japan HER2 Targeted Therapy Market Forecast 10.3.3 Korea HER2 Targeted Therapy Market Forecast 10.3.4 Southeast Asia HER2 Targeted Therapy Market Forecast 10.3.5 India HER2 Targeted Therapy Market Forecast 10.3.6 Australia HER2 Targeted Therapy Market Forecast 10.4 Europe HER2 Targeted Therapy Forecast by Country (2021-2026) 10.4.1 Germany HER2 Targeted Therapy Market Forecast 10.4.2 France HER2 Targeted Therapy Market Forecast 10.4.3 UK HER2 Targeted Therapy Market Forecast 10.4.4 Italy HER2 Targeted Therapy Market Forecast 10.4.5 Russia HER2 Targeted Therapy Market Forecast 10.5 Middle East & Africa HER2 Targeted Therapy Forecast by Region (2021-2026) 10.5.1 Egypt HER2 Targeted Therapy Market Forecast 10.5.2 South Africa HER2 Targeted Therapy Market Forecast 10.5.3 Israel HER2 Targeted Therapy Market Forecast 10.5.4 Turkey HER2 Targeted Therapy Market Forecast 10.5.5 GCC Countries HER2 Targeted Therapy Market Forecast 10.6 Global HER2 Targeted Therapy Forecast by Type (2021-2026) 10.7 Global HER2 Targeted Therapy Forecast by Application (2021-2026) 11 Key Players Analysis 11.1 GlaxoSmithKline 11.1.1 GlaxoSmithKline Company Information 11.1.2 GlaxoSmithKline HER2 Targeted Therapy Product Offered 11.1.3 GlaxoSmithKline HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021) 11.1.4 GlaxoSmithKline Main Business Overview 11.1.5 GlaxoSmithKline Latest Developments 11.2 Bayer 11.2.1 Bayer Company Information 11.2.2 Bayer HER2 Targeted Therapy Product Offered 11.2.3 Bayer HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021) 11.2.4 Bayer Main Business Overview 11.2.5 Bayer Latest Developments 11.3 Abbott 11.3.1 Abbott Company Information 11.3.2 Abbott HER2 Targeted Therapy Product Offered 11.3.3 Abbott HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021) 11.3.4 Abbott Main Business Overview 11.3.5 Abbott Latest Developments 11.4 AbbVie 11.4.1 AbbVie Company Information 11.4.2 AbbVie HER2 Targeted Therapy Product Offered 11.4.3 AbbVie HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021) 11.4.4 AbbVie Main Business Overview 11.4.5 AbbVie Latest Developments 11.5 Pfizer 11.5.1 Pfizer Company Information 11.5.2 Pfizer HER2 Targeted Therapy Product Offered 11.5.3 Pfizer HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021) 11.5.4 Pfizer Main Business Overview 11.5.5 Pfizer Latest Developments 11.6 Sanofi 11.6.1 Sanofi Company Information 11.6.2 Sanofi HER2 Targeted Therapy Product Offered 11.6.3 Sanofi HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021) 11.6.4 Sanofi Main Business Overview 11.6.5 Sanofi Latest Developments 11.7 Agilent 11.7.1 Agilent Company Information 11.7.2 Agilent HER2 Targeted Therapy Product Offered 11.7.3 Agilent HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021) 11.7.4 Agilent Main Business Overview 11.7.5 Agilent Latest Developments 11.8 Glenmark Pharmaceuticals 11.8.1 Glenmark Pharmaceuticals Company Information 11.8.2 Glenmark Pharmaceuticals HER2 Targeted Therapy Product Offered 11.8.3 Glenmark Pharmaceuticals HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021) 11.8.4 Glenmark Pharmaceuticals Main Business Overview 11.8.5 Glenmark Pharmaceuticals Latest Developments 11.9 Merck 11.9.1 Merck Company Information 11.9.2 Merck HER2 Targeted Therapy Product Offered 11.9.3 Merck HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021) 11.9.4 Merck Main Business Overview 11.9.5 Merck Latest Developments 11.10 Roche 11.10.1 Roche Company Information 11.10.2 Roche HER2 Targeted Therapy Product Offered 11.10.3 Roche HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021) 11.10.4 Roche Main Business Overview 11.10.5 Roche Latest Developments 11. Novartis 11.11.1 Novartis Company Information 11.11.2 Novartis HER2 Targeted Therapy Product Offered 11.11.3 Novartis HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021) 11.11.4 Novartis Main Business Overview 11.11.5 Novartis Latest Developments 11.12 Astra Zeneca 11.12.1 Astra Zeneca Company Information 11.12.2 Astra Zeneca HER2 Targeted Therapy Product Offered 11.12.3 Astra Zeneca HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021) 11.12.4 Astra Zeneca Main Business Overview 11.12.5 Astra Zeneca Latest Developments 11.13 Daiichi Sankyo 11.13.1 Daiichi Sankyo Company Information 11.13.2 Daiichi Sankyo HER2 Targeted Therapy Product Offered 11.13.3 Daiichi Sankyo HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021) 11.13.4 Daiichi Sankyo Main Business Overview 11.13.5 Daiichi Sankyo Latest Developments 12 Research Findings and Conclusion

List of Tables Table 1. HER2 Targeted Therapy Market Size CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Monotherapy Table 3. Major Players of Combination Therapy Table 4. Major Players of Others Table 5. HER2 Targeted Therapy Market Size CAGR by Type (2020-2026) & ($ Millions) Table 6. Global HER2 Targeted Therapy Market Size by Type (2016-2021) & ($ Millions) Table 7. Global HER2 Targeted Therapy Market Size Market Share by Type (2016-2021) Table 8. HER2 Targeted Therapy Market Size CAGR by Application (2016-2021) & ($ Millions) Table 9. Global HER2 Targeted Therapy Market Size by Application (2016-2021) & ($ Millions) Table 10. Global HER2 Targeted Therapy Market Size Market Share by Application (2016-2021) Table 11. Global HER2 Targeted Therapy Revenue by Players (2019-2021E) & ($ Millions) Table 12. Global HER2 Targeted Therapy Revenue Market Share by Players (2019-2021E) Table 13. HER2 Targeted Therapy Key Players Head office and Products Offered Table 14. HER2 Targeted Therapy Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E) Table 15. New Products and Potential Entrants Table 16. Mergers & Acquisitions, Expansion Table 17. Global HER2 Targeted Therapy Market Size by Regions 2016-2021 & ($ Millions) Table 18. Global HER2 Targeted Therapy Market Size Market Share by Regions 2016-2021 Table 19. Americas HER2 Targeted Therapy Market Size by Country (2016-2021) & ($ Millions) Table 20. Americas HER2 Targeted Therapy Market Size Market Share by Country (2016-2021) Table 21. Americas HER2 Targeted Therapy Market Size by Type (2016-2021) & ($ Millions) Table 22. Americas HER2 Targeted Therapy Market Size Market Share by Type (2016-2021) Table 23. Americas HER2 Targeted Therapy Market Size by Application (2016-2021) & ($ Millions) Table 24. Americas HER2 Targeted Therapy Market Size Market Share by Application (2016-2021) Table 25. APAC HER2 Targeted Therapy Market Size by Region (2016-2021) & ($ Millions) Table 26. APAC HER2 Targeted Therapy Market Size Market Share by Region (2016-2021) Table 27. APAC HER2 Targeted Therapy Market Size by Type (2016-2021) & ($ Millions) Table 28. APAC HER2 Targeted Therapy Market Size Market Share by Type (2016-2021) Table 29. APAC HER2 Targeted Therapy Market Size by Application (2016-2021) & ($ Millions) Table 30. APAC HER2 Targeted Therapy Market Size Market Share by Application (2016-2021) Table 31. Europe HER2 Targeted Therapy Market Size by Country (2016-2021) & ($ Millions) Table 32. Europe HER2 Targeted Therapy Market Size Market Share by Country (2016-2021) Table 33. Europe HER2 Targeted Therapy Market Size by Type (2016-2021) & ($ Millions) Table 34. Europe HER2 Targeted Therapy Market Size Market Share by Type (2016-2021) Table 35. Europe HER2 Targeted Therapy Market Size by Application (2016-2021) & ($ Millions) Table 36. Europe HER2 Targeted Therapy Market Size Market Share by Application (2016-2021) Table 37. Middle East & Africa HER2 Targeted Therapy Market Size by Region (2016-2021) & ($ Millions) Table 38. Middle East & Africa HER2 Targeted Therapy Market Size Market Share by Region (2016-2021) Table 39. Middle East & Africa HER2 Targeted Therapy Market Size by Type (2016-2021) & ($ Millions) Table 40. Middle East & Africa HER2 Targeted Therapy Market Size Market Share by Type (2016-2021) Table 41. Middle East & Africa HER2 Targeted Therapy Market Size by Application (2016-2021) & ($ Millions) Table 42. Middle East & Africa HER2 Targeted Therapy Market Size Market Share by Application (2016-2021) Table 43. Key and Potential Regions of HER2 Targeted Therapy Table 44. Key Application and Potential Industries of HER2 Targeted Therapy Table 45. Key Challenges of HER2 Targeted Therapy Table 46. Key Trends of HER2 Targeted Therapy Table 47. Global HER2 Targeted Therapy Market Size Forecast by Regions (2021-2026) & ($ Millions) Table 48. Global HER2 Targeted Therapy Market Size Market Share Forecast by Regions (2021-2026) Table 49. Global HER2 Targeted Therapy Market Size Forecast by Type (2021-2026) & ($ Millions) Table 50. Global HER2 Targeted Therapy Market Size Market Share Forecast by Type (2021-2026) Table 51. Global HER2 Targeted Therapy Market Size Forecast by Application (2021-2026) & ($ Millions) Table 52. Global HER2 Targeted Therapy Market Size Market Share Forecast by Application (2021-2026) Table 53. GlaxoSmithKline Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors Table 54. GlaxoSmithKline HER2 Targeted Therapy Product Offered Table 55. GlaxoSmithKline HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 56. GlaxoSmithKline Main Business Table 57. GlaxoSmithKline Latest Developments Table 58. Bayer Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors Table 59. Bayer HER2 Targeted Therapy Product Offered Table 60. Bayer Main Business Table 61. Bayer HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 62. Bayer Latest Developments Table 63. Abbott Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors Table 64. Abbott HER2 Targeted Therapy Product Offered Table 65. Abbott Main Business Table 66. Abbott HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 67. Abbott Latest Developments Table 68. AbbVie Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors Table 69. AbbVie HER2 Targeted Therapy Product Offered Table 70. AbbVie Main Business Table 71. AbbVie HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 72. AbbVie Latest Developments Table 73. Pfizer Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors Table 74. Pfizer HER2 Targeted Therapy Product Offered Table 75. Pfizer Main Business Table 76. Pfizer HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 77. Pfizer Latest Developments Table 78. Sanofi Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors Table 79. Sanofi HER2 Targeted Therapy Product Offered Table 80. Sanofi Main Business Table 81. Sanofi HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 82. Sanofi Latest Developments Table 83. Agilent Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors Table 84. Agilent HER2 Targeted Therapy Product Offered Table 85. Agilent Main Business Table 86. Agilent HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 87. Agilent Latest Developments Table 88. Glenmark Pharmaceuticals Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors Table 89. Glenmark Pharmaceuticals HER2 Targeted Therapy Product Offered Table 90. Glenmark Pharmaceuticals Main Business Table 91. Glenmark Pharmaceuticals HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 92. Glenmark Pharmaceuticals Latest Developments Table 93. Merck Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors Table 94. Merck HER2 Targeted Therapy Product Offered Table 95. Merck Main Business Table 96. Merck HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 97. Merck Latest Developments Table 98. Roche Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors Table 99. Roche HER2 Targeted Therapy Product Offered Table 100. Roche Main Business Table 101. Roche HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 102. Roche Latest Developments Table 103. Novartis Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors Table 104. Novartis HER2 Targeted Therapy Product Offered Table 105. Novartis HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 106. Novartis Main Business Table 107. Novartis Latest Developments Table 108. Astra Zeneca Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors Table 109. Astra Zeneca HER2 Targeted Therapy Product Offered Table 110. Astra Zeneca Main Business Table 111. Astra Zeneca HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 112. Astra Zeneca Latest Developments Table 113. Daiichi Sankyo Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors Table 114. Daiichi Sankyo HER2 Targeted Therapy Product Offered Table 115. Daiichi Sankyo Main Business Table 116. Daiichi Sankyo HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 117. Daiichi Sankyo Latest Developments List of Figures Figure 1. HER2 Targeted Therapy Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global HER2 Targeted Therapy Market Size Growth Rate 2016-2026 ($ Millions) Figure 6. Global HER2 Targeted Therapy Market Size Market Share by Type in 2020 Figure 7. HER2 Targeted Therapy in Breast Cancer Figure 8. Global HER2 Targeted Therapy Market: Breast Cancer (2016-2021) & ($ Millions) Figure 9. HER2 Targeted Therapy in Stomach Cancer Figure 10. Global HER2 Targeted Therapy Market: Stomach Cancer (2016-2021) & ($ Millions) Figure 11. HER2 Targeted Therapy in Head and Neck Cancer Figure 12. Global HER2 Targeted Therapy Market: Head and Neck Cancer (2016-2021) & ($ Millions) Figure 13. HER2 Targeted Therapy in Lung Cancer Figure 14. Global HER2 Targeted Therapy Market: Lung Cancer (2016-2021) & ($ Millions) Figure 15. HER2 Targeted Therapy in Ovarian Cancer Figure 16. Global HER2 Targeted Therapy Market: Ovarian Cancer (2016-2021) & ($ Millions) Figure 17. HER2 Targeted Therapy in Others Figure 18. Global HER2 Targeted Therapy Market: Others (2016-2021) & ($ Millions) Figure 19. Global HER2 Targeted Therapy Market Size Market Share by Application in 2020 Figure 20. Global HER2 Targeted Therapy Revenue Market Share by Player in 2020 Figure 21. Global HER2 Targeted Therapy Market Size Market Share by Regions (2016-2021) Figure 22. Americas HER2 Targeted Therapy Market Size 2016-2021 ($ Millions) Figure 23. APAC HER2 Targeted Therapy Market Size 2016-2021 ($ Millions) Figure 24. Europe HER2 Targeted Therapy Market Size 2016-2021 ($ Millions) Figure 25. Middle East & Africa HER2 Targeted Therapy Market Size 2016-2021 ($ Millions) Figure 26. Americas HER2 Targeted Therapy Market Size Market Share by Country in 2020 Figure 27. Americas HER2 Targeted Therapy Market Size Market Share by Type in 2020 Figure 28. Americas HER2 Targeted Therapy Market Size Market Share by Application in 2020 Figure 29. United States HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions) Figure 30. Canada HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions) Figure 31. Mexico HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions) Figure 32. APAC HER2 Targeted Therapy Market Size Market Share by Regions in 2020 Figure 33. APAC HER2 Targeted Therapy Market Size Market Share by Type in 2020 Figure 34. APAC HER2 Targeted Therapy Market Size Market Share by Application in 2020 Figure 35. China HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions) Figure 36. Japan HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions) Figure 37. Korea HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions) Figure 38. Southeast Asia HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions) Figure 39. India HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions) Figure 40. Australia HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions) Figure 41. Europe HER2 Targeted Therapy Market Size Market Share by Country in 2020 Figure 42. Europe HER2 Targeted Therapy Market Size Market Share by Type in 2020 Figure 43. Europe HER2 Targeted Therapy Market Size Market Share by Application in 2020 Figure 44. Germany HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions) Figure 45. France HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions) Figure 46. UK HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions) Figure 47. Italy HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions) Figure 48. Russia HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions) Figure 49. Middle East & Africa HER2 Targeted Therapy Market Size Market Share by Region in 2020 Figure 50. Middle East & Africa HER2 Targeted Therapy Market Size Market Share by Type in 2020 Figure 51. Middle East & Africa HER2 Targeted Therapy Market Size Market Share by Application in 2020 Figure 52. Egypt HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions) Figure 53. South Africa HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions) Figure 54. Israel HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions) Figure 55. Turkey HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions) Figure 56. GCC Country HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions) Figure 57. Americas HER2 Targeted Therapy Market Size 2021-2026 ($ Millions) Figure 58. APAC HER2 Targeted Therapy Market Size 2021-2026 ($ Millions) Figure 59. Europe HER2 Targeted Therapy Market Size 2021-2026 ($ Millions) Figure 60. Middle East & Africa HER2 Targeted Therapy Market Size 2021-2026 ($ Millions) Figure 61. United States HER2 Targeted Therapy Market Size 2021-2026 ($ Millions) Figure 62. Canada HER2 Targeted Therapy Market Size 2021-2026 ($ Millions) Figure 63. Mexico HER2 Targeted Therapy Market Size 2021-2026 ($ Millions) Figure 64. Brazil HER2 Targeted Therapy Market Size 2021-2026 ($ Millions) Figure 65. China HER2 Targeted Therapy Market Size 2021-2026 ($ Millions) Figure 66. Japan HER2 Targeted Therapy Market Size 2021-2026 ($ Millions) Figure 67. Korea HER2 Targeted Therapy Market Size 2021-2026 ($ Millions) Figure 68. Southeast Asia HER2 Targeted Therapy Market Size 2021-2026 ($ Millions) Figure 69. India HER2 Targeted Therapy Market Size 2021-2026 ($ Millions) Figure 70. Australia HER2 Targeted Therapy Market Size 2021-2026 ($ Millions) Figure 71. Germany HER2 Targeted Therapy Market Size 2021-2026 ($ Millions) Figure 72. France HER2 Targeted Therapy Market Size 2021-2026 ($ Millions) Figure 73. UK HER2 Targeted Therapy Market Size 2021-2026 ($ Millions) Figure 74. Italy HER2 Targeted Therapy Market Size 2021-2026 ($ Millions) Figure 75. Russia HER2 Targeted Therapy Market Size 2021-2026 ($ Millions) Figure 76. Spain HER2 Targeted Therapy Market Size 2021-2026 ($ Millions) Figure 77. Egypt HER2 Targeted Therapy Market Size 2021-2026 ($ Millions) Figure 78. South Africa HER2 Targeted Therapy Market Size 2021-2026 ($ Millions) Figure 79. Israel HER2 Targeted Therapy Market Size 2021-2026 ($ Millions) Figure 80. Turkey HER2 Targeted Therapy Market Size 2021-2026 ($ Millions) Figure 81. GCC Country HER2 Targeted Therapy Market Size 2021-2026 ($ Millions)